SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are...
FY 2023
Dec 31, 2023
Q3 2023
Nov 8, 2023
Q2 2023
Aug 14, 2023
Q1 2023
May 15, 2023
FY 2022
Mar 28, 2023
